{"symbol":"PFE","fiscalQuarter":"Q3-2013","reportDate":"2013-10-29","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2013","postBrief":{"headline":"Pfizer Beats on EPS, Stock Up 1.66%","keyNumbers":[{"metric":"EPS","actual":"$0.58","expected":"N/A","surprise":"+3.76%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS results despite not providing revenue figures.","They emphasized ongoing efforts in research and development."],"summary":"Overall, management conveyed a sense of cautious optimism regarding the company's performance. They highlighted the importance of their ongoing projects."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report shows a positive surprise in EPS, which contributed to a 1.66% increase in stock price. The lack of revenue data leaves some uncertainty, but management's optimistic tone suggests confidence in future performance. Investors may view the EPS beat as a sign of underlying strength in the company's operations.","metaDescription":"Pfizer Inc (PFE) Q3 2013 earnings: EPS beat by 3.76%. Stock up 1.66%. Full breakdown."}}